Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily

Cytokine

Volumn 71, Issue 2, 2015, Pages 302-311

  Fox, Jamie C ^a   Nakayama, Takashi ^b   Tyler, Robert C ^a   Sander, Tara L ^a   Yoshie, Osamu ^b   Volkman, Brian F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Ca2+ flux; Chemotaxis; Lymphotactin; XCL1; XCL2

Indexed keywords

AMINO ACID; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; GAMMA CHEMOKINE; GLYCOSAMINOGLYCAN; HEPARIN; LYMPHOTACTIN; MONOMER; SODIUM CHLORIDE; CALCIUM; LYMPHOKINE; PROTEIN BINDING; SIALOGLYCOPROTEIN; UREA; XCL1 PROTEIN, HUMAN; XCL2 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING ASSAY; CALCIUM TRANSPORT; CD8+ T LYMPHOCYTE; CHEMOTAXIS; ELUTION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; IN VITRO STUDY; PARALOGY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; TEMPERATURE; THERMODYNAMICS; ANIMAL; BIOLOGY; CHEMISTRY; KINETICS; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PROTEIN DENATURATION; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CHEMOKINES, C; CHEMOTAXIS; COMPUTATIONAL BIOLOGY; HEPARIN; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LYMPHOKINES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; TEMPERATURE; THERMODYNAMICS; UREA;

EID: 84916887047     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.11.010     Document Type: Article

References (62)

1. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354(6):610-621.
2. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338(7):436-445.
3. Le Y., Zhou Y., Iribarren P., Wang J. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol 2004, 1(2):95-104.
4. Murphy P.M. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001, 345(11):833-835.
5. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002, 42:469-499.
6. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12(2):121-127.
7. Yoshida T., Imai T., Kakizaki M., Nishimura M., Takagi S., Yoshie O. Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem 1998, 273(26):16551-16554.
8. Kuloglu E.S., McCaslin D.R., Kitabwalla M., Pauza C.D., Markley J.L., Volkman B.F. Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. Biochemistry 2001, 40(42):12486-12496.
9. Kuloglu E.S., McCaslin D.R., Markley J.L., Volkman B.F. Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J Biol Chem 2002, 277(20):17863-17870.
10. Peterson F.C., Elgin E.S., Nelson T.J., Zhang F., Hoeger T.J., Linhardt R.J., et al. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J Biol Chem 2004, 279(13):12598-12604.
11. Tuinstra R.L., Peterson F.C., Elgin E.S., Pelzek A.J., Volkman B.F. An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity. Biochemistry 2007, 46(10):2564-2573.
12. Tuinstra R.L., Peterson F.C., Kutlesa S., Elgin E.S., Kron M.A., Volkman B.F. Interconversion between two unrelated protein folds in the lymphotactin native state. Proc Natl Acad Sci USA 2008, 105(13):5057-5062.
13. Dorner B., Muller S., Entschladen F., Schroder J.M., Franke P., Kraft R., et al. Purification, structural analysis, and function of natural ATAC, a cytokine secreted by CD8(+) T cells. J Biol Chem 1997, 272(13):8817-8823.
14. Giancarlo B., Silvano S., Albert Z., Mantovani A., Allavena P. Migratory response of human natural killer cells to lymphotactin. Eur J Immunol 1996, 26(12):3238-3241.
15. Kelner G.S., Kennedy J., Bacon K.B., Kleyensteuber S., Largaespada D.A., Jenkins N.A., et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994, 266(5189):1395-1399.
16. Kennedy J., Kelner G.S., Kleyensteuber S., Schall T.J., Weiss M.C., Yssel H., et al. Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995, 155(1):203-209.
17. Muller S., Dorner B., Korthauer U., Mages H.W., D'Apuzzo M., Senger G., et al. Cloning of ATAC, an activation-induced, chemokine-related molecule exclusively expressed in CD8+ T lymphocytes. Eur J Immunol 1995, 25(6):1744-1748.
18. Bachem A., Guttler S., Hartung E., Ebstein F., Schaefer M., Tannert A., et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 2010, 207(6):1273-1281.
19. Crozat K., Guiton R., Contreras V., Feuillet V., Dutertre C.A., Ventre E., et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010, 207(6):1283-1292.
20. Crozat K., Tamoutounour S., Manh T.P., Fossum E., Luche H., Ardouin L., et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8alpha+ type. J Immunol 2011, 187(9):4411-4415.
21. Dorner B.G., Dorner M.B., Zhou X., Opitz C., Mora A., Guttler S., et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity 2009, 31(5):823-833.
22. Lei Y., Ripen A.M., Ishimaru N., Ohigashi I., Nagasawa T., Jeker L.T., et al. Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J Exp Med 2011, 208(2):383-394.
23. Lei Y., Takahama Y. XCL1 and XCR1 in the immune system. Microbes Infect 2011.
24. Yoshida T., Imai T., Kakizaki M., Nishimura M., Yoshie O. Molecular cloning of a novel C or gamma type chemokine, SCM-1. FEBS Lett 1995, 360(2):155-159.
25. Yoshida T., Imai T., Takagi S., Nishimura M., Ishikawa I., Yaoi T., et al. Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett 1996, 395(1):82-88.
26. Yamazaki C., Miyamoto R., Hoshino K., Fukuda Y., Sasaki I., Saito M., et al. Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice. Biochem Biophys Res Commun 2010, 397(4):756-761.
27. Hennemann B., Tam Y.K., Tonn T., Klingemann H.G. Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol 1999, 18(7):565-571.
28. Wang M., Windgassen D., Papoutsakis E.T. Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation. BMC Genomics 2008, 9:225.
29. Zimmerman J.W., Pennison M.J., Brezovich I., Yi N., Yang C.T., Ramaker R., et al. Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer 2012, 106(2):307-313.
30. Kim M., Rooper L., Xie J., Rayahin J., Burdette J.E., Kajdacsy-Balla A.A., et al. The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation. Mol Cancer Res: MCR 2012, 10(11):1419-1429.
31. Kiaii S., Kokhaei P., Mozaffari F., Rossmann E., Pak F., Moshfegh A., et al. T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile. Cancer Immunol Immunother 2013, 62(1):51-63.
32. Cao W., Tang S., Yuan H., Wang H., Zhao X., Lu H. Mycobacterium tuberculosis antigen Wag31 induces expression of C-chemokine XCL2 in macrophages. Curr Microbiol 2008, 57(3):189-194.
33. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997, 16(23):6996-7007.
34. Clamp M., Cuff J., Searle S.M., Barton G.J. The Jalview Java alignment editor. Bioinformatics 2004, 20(3):426-427.
35. Waterhouse A.M., Procter J.B., Martin D.M., Clamp M., Barton G.J. Jalview version 2 - a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25(9):1189-1191.
36. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995, 6(3):277-293.
37. Computer-aided resonance assignment (CARA). <>. http://www.nmr.ch.
38. Bartels C., Xia T.H., Billeter M., Gunter P., Wuthrich K. The program XEASY for computer-spoorted NMR spectral analysis of biological macromolecules. J Biomol NMR 1995, 6(1):1-10.
39. Tyler R.C., Wieting J.C., Peterson F.C., Volkman B.F. Electrostatic optimization of the conformational energy landscape in a metamorphic protein. Biochemistry 2012, 51(45):9067-9075.
40. Shirley B.A. Urea and guanidine hydrochloride denaturation curves. Methods Mol Biol 1995, 40:177-190.
41. Shan L., Qiao X., Oldham E., Catron D., Kaminski H., Lundell D., et al. Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1. Biochem Biophys Res Commun 2000, 268(3):938-941.
42. Keller RLJ. Computer aided resonance assignment tutorial: Cantina; 2004.
43. Hamel D.J., Sielaff I., Proudfoot A.E., Handel T.M. Chapter 4. Interactions of chemokines with glycosaminoglycans. Methods Enzymol 2009, 461:71-102.
44. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem 2005, 74:385-410.
45. Baoprasertkul P., He C., Peatman E., Zhang S., Li P., Liu Z. Constitutive expression of three novel catfish CXC chemokines: homeostatic chemokines in teleost fish. Mol Immunol 2005, 42(11):1355-1366.
46. Huising M.O., Stet R.J., Kruiswijk C.P., Savelkoul H.F., Lidy Verburg-van Kemenade B.M. Molecular evolution of CXC chemokines: extant CXC chemokines originate from the CNS. Trends Immunol 2003, 24(6):307-313.
47. Calabrese E.J. Cell migration/chemotaxis: biphasic dose responses. Crit Rev Toxicol 2001, 31(4-5):615-624.
48. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A 2003, 100(4):1885-1890.
49. Menkin V., Warner C.R. Studies on Inflammation: XIII. Carbohydrate metabolism, local acidosis, and the cytological picture in inflammation. Am J Pathol 1937, 13(1):25-44 21.
50. Ihrcke N.S., Parker W., Reissner K.J., Platt J.L. Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 1998, 175(3):255-267.
51. Xu L., Fidler I.J. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 2000, 60(16):4610-4616.
52. Ogata R., Hiramatsu N., Hayakawa K., Nakajima S., Yao J., Kobayashi T., et al. Impairment of MCP-1 expression in mesothelial cells exposed to peritoneal dialysis fluid by osmotic stress and acidic stress. Perit Dial Int 2011, 31(1):80-89.
53. Rofstad E.K., Mathiesen B., Kindem K., Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006, 66(13):6699-6707.
54. Nugent S.G., Kumar D., Rampton D.S., Evans D.F. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 2001, 48(4):571-577.
55. Yoshida T., Ishikawa I., Ono Y., Imai T., Suzuki R., Yoshie O. An activation-responsive element in single C motif-1/lymphotactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell. J Immunol 1999, 163(6):3295-3303.
56. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005, 5(6):472-484.
57. Lambeir A.M., Durinx C., Proost P., Van Damme J., Scharpe S., De Meester I. Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett 2001, 507(3):327-330.
58. Loos T., Mortier A., Gouwy M., Ronsse I., Put W., Lenaerts J.P., et al. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 2008, 112(7):2648-2656.
59. Marcaurelle L.A., Mizoue L.S., Wilken J., Oldham L., Kent S.B., Handel T.M., et al. Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain. Chemistry 2001, 7(5):1129-1132.
60. Dong C., Chua A., Ganguly B., Krensky A.M., Clayberger C. Glycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activity. J Immunol Methods 2005, 302(1-2):136-144.
61. Ohno S. Gene duplication and the uniqueness of vertebrate genomes circa 1970-1999. Semin Cell Dev Biol 1999, 10(5):517-522.
62. Hughes T., Ekman D., Ardawatia H., Elofsson A., Liberles D.A. Evaluating dosage compensation as a cause of duplicate gene retention in Paramecium tetraurelia. Genome Biol 2007, 8(5):213.